Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FWA99
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,361
Award facts
- Contract value 100% obligated
- $15,360.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,360.64 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract represents a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is issued without a set-aside designation, indicating it was competitively awarded. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies critical medical commodities to federal military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, ranging from specialty medications to brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Dupixent, a biologic medication used to treat inflammatory conditions, reflects the company's role as a key vendor supporting the Defense Health Agency and broader military healthcare operations through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FWA99?
SPE2DB25FWA99 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FWA99 worth?
The government has obligated $15,361 on SPE2DB25FWA99.
Is contract SPE2DB25FWA99 an order under another contract?
Yes. SPE2DB25FWA99 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWA99 competed?
The extent of competition for SPE2DB25FWA99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award